Welcome to Heart Matters – Empowering Heart Health
Medications Hub

What Does Gout Have in Common with Your Heart?

When most people think of gout, they imagine a painful, swollen big toe. But what if this common form of arthritis has more to do with your heart than you might expect?

What Does Gout Have in Common with Your Heart?

Over the past decade, researchers have been uncovering important links between gout, inflammation, and heart disease. More recently, the medication often used to treat gout — colchicine — is being studied for its potential role in preventing heart attacks and improving outcomes in people with cardiovascular disease. Let us explore how this ancient remedy is finding new life in modern cardiology.

A Quick Look at Gout

Gout is a type of arthritis caused by a buildup of uric acid in the blood. When uric acid levels rise too high, it can form crystals that deposit in joints, leading to sudden episodes of pain, redness, and swelling.

Gout has long been associated with dietary factors, alcohol intake, and other conditions such as high blood pressure and kidney disease. Interestingly, these same factors are also linked to an increased risk of heart disease.

The Common Thread: Inflammation

The key connection between gout and the heart lies in inflammation. Both gout and cardiovascular disease involve an overactive inflammatory response. In fact, inflammation plays a major role in the formation and rupture of plaques in coronary arteries — the main cause of heart attacks.

When a plaque ruptures, it triggers the body’s immune system, much like an attack of gout does. This inflammation can lead to clot formation and blockage of the artery. Understanding and targeting this process has opened new doors for heart disease treatment.

Colchicine: An Old Drug with New Potential

Colchicine has been used for centuries to treat gout. It works by calming the body’s inflammatory response, particularly by inhibiting the activity of white blood cells.

In recent years, researchers have asked: if colchicine can reduce inflammation in gout, could it also reduce inflammation in the arteries and prevent heart attacks?

The answer appears to be promising.

Colchicine and Pericarditis

Colchicine has been a mainstay in the treatment of pericarditis, a condition where the lining around the heart becomes inflamed. This can cause sharp chest pain that worsens with deep breaths or lying flat. Pericarditis may follow a viral illness, occur after heart surgery, or result from autoimmune conditions.

How It Works

In pericarditis, the aim of treatment is to reduce inflammation and prevent recurrence. Colchicine works by interrupting the inflammatory process, limiting the activity of white blood cells that drive the symptoms. Its effectiveness is supported by multiple clinical trials and international guidelines.

Typical Dosage and Treatment Routine

For acute pericarditis, colchicine is usually prescribed as:

  • 0.5 mg twice daily for people over 70 kg
  • 0.5 mg once daily for those under 70 kg or with lower tolerance

This is typically continued for three months in acute cases. In recurrent pericarditis, treatment may extend to six months or longer.

Colchicine is often given alongside nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen to provide quicker pain relief during the early phase.

It is important to take colchicine with food to reduce the chance of stomach upset and to avoid grapefruit juice, which can interfere with how the drug is processed in the body.

Adverse Effects to Watch For

Colchicine is generally well tolerated, but side effects can occur. The most common include:

  • Gastrointestinal symptoms, such as diarrhoea, nausea, or cramping
  • Fatigue or muscle aches
  • Changes in white blood cell count or mild liver enzyme elevation (uncommon)

Those with kidney or liver disease may need a lower dose or closer monitoring.

Colchicine should be used cautiously with certain other medications, especially those that interfere with liver metabolism or affect the same transport proteins. If symptoms like ongoing diarrhoea, muscle pain, or signs of infection develop, medical review is important.

Colchicine in Coronary Artery Disease

Large clinical trials such as COLCOT and LoDoCo2 have explored the role of low dose colchicine in people with coronary artery disease. These studies showed that colchicine, when taken regularly, can significantly reduce the risk of heart attack, stroke, and the need for urgent procedures.

Importantly, these benefits appear to come without increasing serious side effects for most people, making colchicine a simple and affordable option for reducing cardiovascular risk.

What About Plaque?

One of the most exciting developments in this area is the potential role of colchicine in modifying atherosclerotic plaque — the fatty, inflamed buildup in the arteries. By reducing inflammation, colchicine may help stabilise plaques, making them less likely to rupture.

This has become a central idea in preventive cardiology: not only lowering cholesterol, but also calming inflammation to protect the arteries.

Who Might Benefit?

While colchicine is not yet routinely prescribed for everyone with heart disease, it is being considered for people who have already had a heart attack or who have persistent inflammation despite other therapies.

Your doctor may discuss this option with you if you are at high risk or have ongoing symptoms that could benefit from anti-inflammatory treatment.

Conclusion

The link between gout and heart disease may seem surprising at first, but it highlights an important truth — the body is interconnected, and inflammation does not limit itself to one area.

Colchicine, once a remedy for gout, is now proving to be a valuable tool in the cardiologist’s toolkit. Its role in treating pericarditis is well established, and its potential to prevent heart attacks and stabilise plaque continues to generate global research interest.

As always, speak with your healthcare provider before starting any new medication. Colchicine is not suitable for everyone, but for many, it may offer another layer of protection in maintaining heart health.

About the author

Heart Matters, edited by cardiologist Professor Peter Barlis, is a trusted resource that offers clear and accurate information on cardiovascular health. It bridges the gap between scientific research and everyday understanding, empowering you to make informed choices and take an active role in supporting your heart health.

Our Youtube Channel

Discover our Heart Matters YouTube channel, where we bring heart health to life. From explaining common conditions and symptoms to discussing the latest research, our engaging videos simplify complex topics, ensuring you have access to valuable knowledge for a healthier heart. Subscribe now and embark on a journey of education, empowerment, and inspiration.

Subscribe to our newsletter and be the first to receive valuable insights, tips, and resources on heart health.

other anti-anginals

When first-line therapies for angina, such as beta blockers, calcium channel blockers, and nitrates, prove inadequate or are not well-tolerated, second-line therapies may be considered.
Perhexiline is a unique medication that enhances the heart's ability to utilize fatty acids for energy, reducing its reliance on oxygen and lowering oxygen demand. This action helps improve blood flow and alleviates chest pain in some patients with refractory angina.
Nicorandil is another second-line option with a dual mechanism of action. It opens potassium channels in smooth muscle cells, causing vasodilation and enhancing coronary blood flow. Additionally, nicorandil also stimulates nitric oxide release, further dilating blood vessels and reducing heart workload.
Trimetazidine is an anti-ischemic agent that improves cardiac efficiency by enhancing glucose metabolism and shifting the heart's energy production to a more oxygen-efficient process. As second-line therapies, these medications offer alternative approaches for managing angina in individuals who do not respond adequately to first-line treatments or those experiencing side effects from other medications.

lipid lowering therapies

Lipid-lowering therapies are essential in managing coronary artery disease (CAD), a condition where the arteries supplying blood to the heart become narrowed. Among the most commonly prescribed treatments are statins, which reduce cholesterol production in the liver and significantly lower the risk of heart attacks and strokes.

Other medications may be used to target different aspects of lipid metabolism:

  • Ezetimibe helps reduce the absorption of cholesterol in the gut
  • Fibrates lower triglyceride levels
  • Niacin can help raise high-density lipoprotein (HDL) cholesterol

In recent years, a newer class of medications known as PCSK9 inhibitors—such as Repatha (evolocumab)—has become available. These drugs block a specific enzyme involved in cholesterol regulation and can dramatically lower LDL cholesterol, particularly in patients who do not achieve target levels with statins alone.

Together, these therapies provide a range of options to personalise treatment and improve cardiovascular outcomes.

Nitrates

Nitrates for Angina Relief

Nitrates are widely used to treat angina and provide quick relief from chest pain. These medications are commonly available as sublingual sprays or tablets, skin patches, and long-acting tablets.

Nitrates work by dilating blood vessels, allowing for increased blood flow and reduced vascular resistance. This reduces the heart’s workload and lowers its oxygen demand, offering prompt relief from angina symptoms.

Sublingual nitrates act quickly and are typically used at the onset of angina symptoms, while patches and long-acting tablets are used for ongoing prevention.

Common side effects include headaches, dizziness, and flushing. These often improve with continued use but should be discussed with a healthcare provider if persistent or bothersome.

calcium channel blockers

Calcium channel blockers, including amlodipine, felodipine, Cardizem (diltiazem), and verapamil, are commonly prescribed for the treatment of angina.

These medications work by inhibiting the influx of calcium into the muscle cells of the heart and blood vessels, causing them to relax. This relaxation leads to the widening of blood vessels, which improves blood flow and reduces blood pressure.

For individuals with angina, calcium channel blockers reduce the heart’s workload and oxygen demand, helping to relieve chest pain and prevent angina episodes.

While effective, they may cause side effects such as headaches, dizziness, facial flushing, and ankle swelling. These effects should be monitored and discussed with your healthcare provider if they persist.

Beta blockers

Beta blockers, such as metoprolol, propranolol, atenolol, carvedilol, and bisoprolol, play a crucial role in managing angina.

These medications work by blocking specific receptors in the heart, which slows the heart rate and reduces the strength of each contraction. This results in a lower oxygen demand by the heart and helps relieve chest pain associated with angina.

Beta blockers are highly effective in both relieving symptoms and preventing angina episodes. However, they may cause side effects in some individuals, including tiredness, worsened asthma symptoms, more vivid dreams, and erectile dysfunction in some males.

It is important to consult your healthcare provider to determine whether beta blockers are a suitable option for your angina and overall heart health.

Anti-platelet Medications

Anti-platelet medications play a crucial role in preventing blood clot formation and reducing the risk of serious cardiovascular events such as heart attacks and strokes. Commonly used agents include aspirin, clopidogrel, and ticagrelor.

 

Aspirin: This well-known medication inhibits platelet activation, reducing the likelihood that platelets will clump together and form clots. It is widely used for both primary and secondary prevention of heart attacks and strokes.

 

Clopidogrel: A potent anti-platelet agent, clopidogrel works by blocking specific receptors on platelets to prevent aggregation. It is commonly prescribed for patients with acute coronary syndrome, those undergoing stent placement, and some individuals with peripheral arterial disease.

 

Ticagrelor: Ticagrelor also inhibits platelet activation and is typically used in the treatment of acute coronary syndrome. It is often prescribed alongside aspirin to provide dual anti-platelet therapy and further reduce the risk of heart-related events.